Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Hillevax Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
HLVX
Nasdaq
8731
https://www.hillevax.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Hillevax Inc
Director Aditya Kohli Sells 18,000 Shares of HilleVax Inc (HLVX)
- Mar 21st, 2024 6:32 am
HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company Progress
- Mar 20th, 2024 8:00 pm
HilleVax to Present at Guggenheim 6th Annual Biotechnology Conference
- Feb 5th, 2024 9:05 pm
HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating Officer
- Jan 18th, 2024 12:00 pm
HilleVax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of China
- Jan 8th, 2024 12:00 pm
HilleVax to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Jan 3rd, 2024 11:28 pm
Insider Sell Alert: Chief Medical Officer Astrid Borkowski Sells 10,000 Shares of HilleVax Inc ...
- Dec 19th, 2023 6:01 pm
Insider Sell Alert: Chief Medical Officer Astrid Borkowski Sells 20,000 Shares of HilleVax Inc ...
- Dec 6th, 2023 2:48 am
Wall Street Analysts Believe HilleVax, Inc. (HLVX) Could Rally 92.19%: Here's is How to Trade
- Nov 30th, 2023 2:55 pm
HilleVax, Inc. (HLVX) Moves to Buy: Rationale Behind the Upgrade
- Nov 14th, 2023 5:00 pm
Does HilleVax, Inc. (HLVX) Have the Potential to Rally 107.23% as Wall Street Analysts Expect?
- Nov 14th, 2023 2:55 pm
HilleVax Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
- Nov 9th, 2023 9:05 pm
HilleVax to Present at Upcoming Investor Conferences
- Nov 1st, 2023 8:48 pm
HilleVax to Participate in Fireside Chat at the 2023 Cantor Global Healthcare Conference
- Sep 26th, 2023 8:01 pm
HilleVax Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
- Sep 25th, 2023 11:00 am
Owning 32% shares,institutional owners seem interested in HilleVax, Inc. (NASDAQ:HLVX),
- Sep 23rd, 2023 2:08 pm
HilleVax Announces Pricing of Public Offering of Common Stock
- Sep 20th, 2023 12:05 am
HilleVax Announces Proposed Public Offering of Common Stock
- Sep 19th, 2023 8:09 pm
J.P. Morgan Sees up to 110% Gains in These 2 Stocks — Here’s Why They Could Soar
- Aug 24th, 2023 2:40 pm
HilleVax Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
- Aug 14th, 2023 11:00 am
Scroll